209 related articles for article (PubMed ID: 36927960)
21. Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis.
Ma YL; Kong CY; Guo Z; Wang MY; Wang P; Liu FY; Yang D; Yang Z; Tang QZ
Nat Commun; 2024 Jun; 15(1):4757. PubMed ID: 38834564
[TBL] [Abstract][Full Text] [Related]
22. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
[TBL] [Abstract][Full Text] [Related]
23. Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts.
Ritterhoff J; McMillen TS; Villet O; Young S; Kolwicz SC; Senn T; Caudal A; Tian R
J Mol Cell Cardiol; 2021 Sep; 158():1-10. PubMed ID: 33989657
[TBL] [Abstract][Full Text] [Related]
24. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
[TBL] [Abstract][Full Text] [Related]
26. Biphasic response of skeletal muscle mitochondria to chronic cardiac pressure overload - role of respiratory chain complex activity.
Schrepper A; Schwarzer M; Schöpe M; Amorim PA; Doenst T
J Mol Cell Cardiol; 2012 Jan; 52(1):125-35. PubMed ID: 22100228
[TBL] [Abstract][Full Text] [Related]
27. The p65 subunit of NF-κB involves in RIP140-mediated inflammatory and metabolic dysregulation in cardiomyocytes.
Zhang L; Chen Y; Yue Z; He Y; Zou J; Chen S; Liu M; Chen X; Liu Z; Liu X; Feng X; Li M; Liu P
Arch Biochem Biophys; 2014 Jul; 554():22-7. PubMed ID: 24823858
[TBL] [Abstract][Full Text] [Related]
28. The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle.
Seth A; Steel JH; Nichol D; Pocock V; Kumaran MK; Fritah A; Mobberley M; Ryder TA; Rowlerson A; Scott J; Poutanen M; White R; Parker M
Cell Metab; 2007 Sep; 6(3):236-45. PubMed ID: 17767910
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling.
Schilling J; Lai L; Sambandam N; Dey CE; Leone TC; Kelly DP
Circ Heart Fail; 2011 Jul; 4(4):474-82. PubMed ID: 21558447
[TBL] [Abstract][Full Text] [Related]
30. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.
Wang P; Liu J; Li Y; Wu S; Luo J; Yang H; Subbiah R; Chatham J; Zhelyabovska O; Yang Q
Circ Res; 2010 Mar; 106(5):911-9. PubMed ID: 20075336
[TBL] [Abstract][Full Text] [Related]
32. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway.
Zheng P; Wu H; Gu Y; Li L; Hu R; Ma W; Bian Z; Liu N; Yang D; Chen X
Biomed Pharmacother; 2023 Jan; 157():114024. PubMed ID: 36402030
[TBL] [Abstract][Full Text] [Related]
34. Cardiomyocyte-specific miR-100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36.
Smolka C; Schlösser D; Koentges C; Tarkhnishvili A; Gorka O; Pfeifer D; Bemtgen X; Asmussen A; Groß O; Diehl P; Moser M; Bode C; Bugger H; Grundmann S; Pankratz F
FASEB J; 2021 Nov; 35(11):e21956. PubMed ID: 34605573
[TBL] [Abstract][Full Text] [Related]
35. Sustained Oligomycin Sensitivity Conferring Protein Expression in Cardiomyocytes Protects Against Cardiac hypertrophy Induced by Pressure Overload via Improving Mitochondrial Function.
Guo Y; Zhang K; Gao X; Zhou Z; Liu Z; Yang K; Huang K; Yang Q; Long Q
Hum Gene Ther; 2020 Nov; 31(21-22):1178-1189. PubMed ID: 32787458
[TBL] [Abstract][Full Text] [Related]
36. GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.
Pereira RO; Wende AR; Olsen C; Soto J; Rawlings T; Zhu Y; Riehle C; Abel ED
J Mol Cell Cardiol; 2014 Jul; 72():95-103. PubMed ID: 24583251
[TBL] [Abstract][Full Text] [Related]
37. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
38. Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Obinata H; Yamaguchi A; Hanaoka H; Hishiki T; Hayakawa N; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Sci Rep; 2018 Aug; 8(1):12035. PubMed ID: 30104639
[TBL] [Abstract][Full Text] [Related]
39. PPAR signaling in the control of cardiac energy metabolism.
Barger PM; Kelly DP
Trends Cardiovasc Med; 2000 Aug; 10(6):238-45. PubMed ID: 11282301
[TBL] [Abstract][Full Text] [Related]
40. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.
Lai L; Leone TC; Keller MP; Martin OJ; Broman AT; Nigro J; Kapoor K; Koves TR; Stevens R; Ilkayeva OR; Vega RB; Attie AD; Muoio DM; Kelly DP
Circ Heart Fail; 2014 Nov; 7(6):1022-31. PubMed ID: 25236884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
